Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

87.5%

+0.9% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 2

3(30.0%)

Phase 4

1(10.0%)

Phase 3

1(10.0%)

10Total

N/A(5)

Phase 2(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT03868670Not ApplicableActive Not Recruiting

Responsive Neurostimulation For Loss Of Control Eating

Role: collaborator

NCT05147571Not ApplicableCompleted

RNS System NAUTILUS Study

Role: lead

NCT02403843Completed

RNS® System Epilepsy Post-Approval Study

Role: lead

NCT05339126Phase 2Active Not Recruiting

RNS System LGS Feasibility Study

Role: lead

NCT05120635Not ApplicableRecruiting

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Role: collaborator

NCT02781129Not ApplicableCompleted

Navigation and Free Recall in Chronically Implanted Humans

Role: collaborator

NCT04839601Not ApplicableTerminated

RNS System RESPONSE Study

Role: lead

NCT00572195Phase 4Completed

RNS® System LTT Study

Role: lead

NCT00079781Phase 2Completed

RNS® System Feasibility Study

Role: lead

NCT00264810Phase 3Completed

RNS® System Pivotal Study

Role: lead

NCT00158067Phase 2Completed

Study of an External Responsive Neurostimulator System on Epileptiform Activity

Role: lead

All 11 trials loaded